ESBLANEM
Main information
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
29-8-2017

FDA approves new antibacterial drug
The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.
FDA - U.S. Food and Drug Administration
20-3-2018
![MEROPENEM Injection, Powder, For Solution [Hospira, Inc.]](/web/assets/global/img/flags/us.png)
MEROPENEM Injection, Powder, For Solution [Hospira, Inc.]
Updated Date: Mar 20, 2018 EST
US - DailyMed
8-2-2018
![MEROPENEM AND SODIUM CHLORIDE Injection, Solution [B. Braun Medical Inc.]](/web/assets/global/img/flags/us.png)
MEROPENEM AND SODIUM CHLORIDE Injection, Solution [B. Braun Medical Inc.]
Updated Date: Feb 8, 2018 EST
US - DailyMed
31-1-2018
![MERREM IV (Meropenem) Injection [AstraZeneca Pharmaceuticals LP]](/web/assets/global/img/flags/us.png)
MERREM IV (Meropenem) Injection [AstraZeneca Pharmaceuticals LP]
Updated Date: Jan 31, 2018 EST
US - DailyMed
16-1-2018
![MEROPENEM Injection, Powder, For Solution [Par Pharmaceutical, Inc.]](/web/assets/global/img/flags/us.png)
MEROPENEM Injection, Powder, For Solution [Par Pharmaceutical, Inc.]
Updated Date: Jan 16, 2018 EST
US - DailyMed
6-11-2017
![MEROPENEM Injection, Powder, For Solution [Amneal Biosciences LLC]](/web/assets/global/img/flags/us.png)
MEROPENEM Injection, Powder, For Solution [Amneal Biosciences LLC]
Updated Date: Nov 6, 2017 EST
US - DailyMed
1-11-2017
![MEROPENEM Injection, Powder, For Solution [BluePoint Laboratories]](/web/assets/global/img/flags/us.png)
MEROPENEM Injection, Powder, For Solution [BluePoint Laboratories]
Updated Date: Nov 1, 2017 EST
US - DailyMed
2-10-2017
![VABOMERE (Meropenem-Vaborbactam) Injection, Powder, For Solution [The Medicines Company]](/web/assets/global/img/flags/us.png)
VABOMERE (Meropenem-Vaborbactam) Injection, Powder, For Solution [The Medicines Company]
Updated Date: Oct 2, 2017 EST
US - DailyMed